Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial-Reference-Cited by-同舟云学术

Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial

Published:2022-07-08 Issue:1 Volume:23 Page:8-22
ISSN:1530-7085
Container-title:Pain Practice
language:en
Short-container-title:Pain Practice

Author:

Viscusi Eugene R.¹^ORCID,de Leon‐Casasola Oscar²^ORCID,Cebrecos Jesús³^ORCID,Jacobs Adam⁴^ORCID,Morte Adelaida³^ORCID,Ortiz Esther³^ORCID,Sust Mariano³^ORCID,Vaqué Anna³^ORCID,Gottlieb Ira⁵,Daniels Stephen⁶,Gimbel Joseph S.⁷,Muse Derek⁸,Winkle Peter⁹,Kuss Michael E.¹⁰,Videla Sebastián³^ORCID,Gascón Neus³^ORCID,Plata‐Salamán Carlos³

Affiliation:

1. Department of Anesthesiology Sidney Kimmel Medical College, Thomas Jefferson University Philadelphia Pennsylvania USA

2. Department of Anesthesiology University of Buffalo/Roswell Park Cancer Institute Buffalo New York USA

3. ESTEVE Pharmaceuticals S.A Barcelona Spain

4. Premier Research Reading UK

5. Chesapeake Research Group LLC Pasadena Maryland USA

6. Optimal Research LLC Austin Texas USA

7. Arizona Research Center Phoenix Arizona USA

8. JBR Clinical Research Salt Lake City Utah USA

9. Anaheim Clinical Trials LLC Anaheim California USA

10. Premier Research Durham North Carolina USA

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/papr.13136

Reference29 articles.

1. FDA.US Food and Drug Administration. Prescribing information SEGLENTIS.2021. Available at:https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213426s000lbl.pdf. Accessed November 9 2021.

Co-crystals as a new approach to multimodal analgesia and the treatment of pain

3. Co-crystal of tramadol-celecoxib: preclinical and clinical evaluation of a novel analgesic

4. Co-crystal of Tramadol Hydrochloride–Celecoxib (ctc): A Novel API–API Co-crystal for the Treatment of Pain

5. Differential Solution Behavior of the New API–API Co-Crystal of Tramadol–Celecoxib (CTC) versus Its Constituents and Their Combination

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrophotometric determination of celecoxib and tramadol in the new approved formulated dosage form using principle component regression assistive model;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-11

2. Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial;Pain Practice;2024-07-02

3. Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials;Drugs in R&D;2024-06

4. Corrigendum;Pain Practice;2024-04-21

5. Indomethacin-omeprazole as therapeutic hybrids? Salt and co-amorphous systems enhancing physicochemical and pharmacological properties;International Journal of Pharmaceutics;2024-03